Key result
This review summarizes the current status of HbA1c biosensors based on the recognition of the sugar moiety on the protein and their applications in whole blood sample measurements.
This review summarizes the current status of HbA1c biosensors based on sugar moiety recognition and their applications in whole blood measurements.
HbA1c biosensor progress merits continued development; leaves open rigorous clinical validation before routine use.
Glycated hemoglobin (HbA1c) is formed via non-enzymatic glycosylation reactions at the α-amino group of βVal1 residues in the tetrameric Hb, and it can reflect the ambient glycemic level over the past two to three months. A variety of HbA1c detection methods, including chromatography, immunoassay, enzymatic measurement, electrochemical sensor and capillary electrophoresis have been developed and used in research laboratories and in clinics as well. In this review, we summarize the current status of HbA1c biosensors based on the recognition of the sugar moiety on the protein and also their applications in the whole blood sample measurements.
No takes yet. Share an insight, caveat, or question.
Hua et al. (2017) reported a review. HbA1c biosensors was evaluated. This review summarizes the current status of HbA1c biosensors based on the recognition of the sugar moiety on the protein and their applications in whole blood sample measurements.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: